Revolution Medicines (RVMD) Shares Issued (2019 - 2026)

Revolution Medicines' Shares Issued history runs 8 years deep, the most recent figure standing at $19.4 million for Q1 2026.

• On a quarterly basis, Shares Issued rose 137.5% year-over-year to $19.4 million in Q1 2026; TTM through Mar 2026 was $19.4 million, a 137.5% increase from a year earlier, with the FY2025 full-year figure at $18.0 million, up 28.69% from the prior year.
• Shares Issued climbed to $19.4 million in Q1 2026 per RVMD's latest filing, from $18.0 million in the prior quarter.
• Across five years, Shares Issued topped out at $19.4 million in Q1 2026 and bottomed at $3.8 million in Q2 2022.
• The 5-year median for Shares Issued is $8.2 million (2022), against an average of $10.2 million.
• Across the five-year window, Shares Issued sank 38.06% in 2023 and jumped 148.21% in 2025, its largest moves.
• Year by year, Shares Issued stood at $8.2 million in 2022, then soared by 35.75% to $11.1 million in 2023, then grew by 26.19% to $14.0 million in 2024, then climbed by 28.69% to $18.0 million in 2025, then climbed by 8.02% to $19.4 million in 2026.
• Per Business Quant, the three latest RVMD Shares Issued figures stand at $19.4 million (Q1 2026), $18.0 million (Q4 2025), and $17.6 million (Q3 2025).